Proteomics in uveal melanoma.

PubWeight™: 0.76‹?›

🔗 View Article (PMID 24056206)

Published in Exp Eye Res on September 19, 2013

Authors

Pathma Ramasamy1, Conor C Murphy2, Martin Clynes3, Noel Horgan4, Paul Moriarty5, Damien Tiernan6, Stephen Beatty7, Susan Kennedy8, Paula Meleady9

Author Affiliations

1: Royal College of Surgeons Ireland, Stephen's Green, Dublin 2, Ireland; National Institute for Cellular Biotechnology, Dublin City University, Collins Avenue, Glasnevin, Dublin 9, Ireland. Electronic address: Pathma.Ramasamy@dcu.ie.
2: Royal College of Surgeons Ireland, Stephen's Green, Dublin 2, Ireland; Royal Victoria Eye and Ear Hospital, Adelaide Road, Dublin 2, Ireland. Electronic address: Conorcmurphy@rcsi.ie.
3: National Institute for Cellular Biotechnology, Dublin City University, Collins Avenue, Glasnevin, Dublin 9, Ireland. Electronic address: Martin.Clynes@dcu.ie.
4: Royal Victoria Eye and Ear Hospital, Adelaide Road, Dublin 2, Ireland. Electronic address: Noel.Horgan@rveeh.ie.
5: Royal Victoria Eye and Ear Hospital, Adelaide Road, Dublin 2, Ireland. Electronic address: paul.moriarty@rveeh.ie.
6: Royal Victoria Eye and Ear Hospital, Adelaide Road, Dublin 2, Ireland. Electronic address: Damien.Tiernan@rveeh.ie.
7: Macular Pigment Research Group, Waterford Institute of Technology, Waterford, Ireland. Electronic address: sbeatty@wit.ie.
8: Royal Victoria Eye and Ear Hospital, Adelaide Road, Dublin 2, Ireland. Electronic address: Susan.Kennedy@rveeh.ie.
9: National Institute for Cellular Biotechnology, Dublin City University, Collins Avenue, Glasnevin, Dublin 9, Ireland. Electronic address: Paula.Meleady@dcu.ie.